Skip to main content
Erschienen in: International Urogynecology Journal 4/2015

01.04.2015 | Special Contribution

Creating a gold standard surgical device: scientific discoveries leading to TVT and beyond

Ulf Ulmsten Memorial Lecture 2014

verfasst von: Peter Petros

Erschienen in: International Urogynecology Journal | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The discovery of tension-free vaginal tape (TVT) began in 1986 with two unrelated observations: pressure applied unilaterally at the midurethra controlled urine loss on coughing; implanted Teflon tape caused a collagenous tissue reaction.

Methods and results

In 1987, Mersilene tape was implanted retropubically in 13 large dogs, with the aim of creating an artificial collagenous pubourethral neoligament. Extensive testing showed that the operation was safe and effective. In 1988–1989, human testing was carried out (n = 30). Mersilene tape cured 100 % of stress and mixed incontinence with a sling in situ; however, there was simultaneous recurrence of the two symptoms in 50 % on sling removal. X-rays showed no elevation of the bladder neck.
In 1990–1993, collaboration with Ulf Ulmsten took place: a permanently implanted tape was required. Polypropylene was the ideal material. In 2003, the neoligament principle was applied as an adjustable “micro” sling to the arcus tendineus fasciae pelvis (ATFP), cardinal, uterosacral ligaments, and perineal body for cure of cystocele, rectocele, and apical prolapse. It was found that symptoms such as urgency, nocturia, chronic pelvic pain, obstructive defecation syndrome (ODS), and fecal incontinence were frequently cured or improved.

Conclusions

The lecture concluded with advice to younger members. Without new paradigms, there are no randomized controlled trials, no meta-analyses, Cochrane. Indeed, no progress. Be open to new concepts. Read Kuhn’s “The Structure of Scientific Revolutions” to understand the discovery process. Examine the relationship among symptoms, ATFP, cardinal, uterosacral ligaments, and the perineal body. This is the next paradigm. Don’t disregard anomalies. Pursue them. They are the pathway to discovery. Innovation is born from challenge, not conformity. Persist, even when meeting resistance. Resistance is a sign that your discovery is important.
Glossar
Anomalies
Occur with internal logical inconsistencies or especially when experimental findings cannot be explained by the existing paradigm.
Crisis
Crises occur when the dominant paradigm fails to solve problems or when the bases or predictions of the paradigm are invalidated.
Incommensurability
Scientific paradigms preceding and succeeding a paradigm shift are so different that their theories are not able to be judged by the same standards. Nor is the change gradual. “Like a gestalt switch, it must occur all at once, or not at all” [1]. Furthermore, the paradigm shift does not merely involve the revision or transformation of an individual theory, it changes the way in which terminology is defined, how the scientists in that field view their subject, and, perhaps most significantly, what questions are regarded as valid, and what rules are used to determine the truth of a particular theory. Examples: the urodynamic paradigm uses pressure readings to guide whether surgery is performed or not. The integral theory paradigm views prolapse and pelvic symptoms as being mainly secondary to ligament laxity, all being surgically repairable.
Normal science
Is when the paradigm is applied to solve puzzles within the context of the dominant paradigm. Examples are the ICS urodynamic paradigm and the integral theory paradigm
Paradigm
Is a conceptual framework that ultimately leads to a widespread consensus on the appropriate choice of methods, terminology, and on the kinds of experiment that are likely to contribute to increased insights.
Scientific revolutions
A totally different paradigm emerges that seeks to explain the phase in which the underlying assumptions of the field are re-examined and a new paradigm is established.
Surgical principle of TVT artificial neoligament
Using a tape implanted precisely in the anatomical position of a ligament (e.g., pubourethral ligament) to restore its structural function.
Literatur
1.
Zurück zum Zitat Kuhn T (1996) The structure of scientific revolutions. University of Chicago Press, Chicago, 3rd edn, pp 1–210CrossRef Kuhn T (1996) The structure of scientific revolutions. University of Chicago Press, Chicago, 3rd edn, pp 1–210CrossRef
3.
Zurück zum Zitat Petros PEP (1999) Development of the intravaginal slingplasty and other ambulatory vaginal surgical procedures. Doctor of surgery thesis, University of Western Australia Petros PEP (1999) Development of the intravaginal slingplasty and other ambulatory vaginal surgical procedures. Doctor of surgery thesis, University of Western Australia
4.
Zurück zum Zitat Petros PE, Ulmsten U, Papadimitriou J (1990) The autogenic neoligament procedure: a technique for planned formation of an artificial neo-ligament. Acta Obstet Gynecol Scand Suppl 153:43–51CrossRefPubMed Petros PE, Ulmsten U, Papadimitriou J (1990) The autogenic neoligament procedure: a technique for planned formation of an artificial neo-ligament. Acta Obstet Gynecol Scand Suppl 153:43–51CrossRefPubMed
5.
Zurück zum Zitat Petros PE, Ulmsten U (1990) The combined intravaginal sling and tuck operation. An ambulatory procedure for stress and urge incontinence. Acta Obstet Gynecol Scand Suppl 153 69:53–59CrossRef Petros PE, Ulmsten U (1990) The combined intravaginal sling and tuck operation. An ambulatory procedure for stress and urge incontinence. Acta Obstet Gynecol Scand Suppl 153 69:53–59CrossRef
6.
Zurück zum Zitat Ulmsten U, Petros P (1995) Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol 1:75–82CrossRef Ulmsten U, Petros P (1995) Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol 1:75–82CrossRef
7.
Zurück zum Zitat Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J 7:81–86CrossRef Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J 7:81–86CrossRef
8.
Zurück zum Zitat Enhorning G (1961) Simultaneous recording of intravesical and intraurethral pressure. A study on urethral closure in normal and stress incontinent women. Acta Chir Scand Suppl 276:1–68PubMed Enhorning G (1961) Simultaneous recording of intravesical and intraurethral pressure. A study on urethral closure in normal and stress incontinent women. Acta Chir Scand Suppl 276:1–68PubMed
9.
Zurück zum Zitat Petros PE, Ulmsten U (1990) An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand Suppl 153 153:7–31 Petros PE, Ulmsten U (1990) An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand Suppl 153 153:7–31
10.
Zurück zum Zitat Van Kerrebroeck P, Andersson K-A (2014) Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn 33 [Suppl 1]:S2–S5 Van Kerrebroeck P, Andersson K-A (2014) Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn 33 [Suppl 1]:S2–S5
13.
Zurück zum Zitat Petros PEP, Richardson PA (2005) The TFS posterior sling for repair of uterine/vault prolapse—a preliminary report. Aust N Z J Obstet Gynaecol 45:376–379CrossRefPubMed Petros PEP, Richardson PA (2005) The TFS posterior sling for repair of uterine/vault prolapse—a preliminary report. Aust N Z J Obstet Gynaecol 45:376–379CrossRefPubMed
Metadaten
Titel
Creating a gold standard surgical device: scientific discoveries leading to TVT and beyond
Ulf Ulmsten Memorial Lecture 2014
verfasst von
Peter Petros
Publikationsdatum
01.04.2015
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 4/2015
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-015-2639-3

Weitere Artikel der Ausgabe 4/2015

International Urogynecology Journal 4/2015 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.